Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

One-Hour nerve zaps could speed up injury recovery

NCT ID NCT05721261

Disease control Sponsor: Epineuron Technologies Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a temporary electrical stimulation system that delivers a single, one-hour therapy to help heal acutely injured peripheral nerves. Researchers will enroll 110 people with recent nerve injuries to see if the treatment is safe and improves sensory recovery. The approach aims to boost the body's natural healing process without long-term medication.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 110 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2023

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: * Peripheral nerve injury Exclusion criteria: * Peripheral neuropathy * Patients with any active implanted device

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Nerve injury are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

traumatic neuropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Nerve injury

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    11 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hamilton General Hospital

    RECRUITING

    Hamilton, Ontario, Canada

  • Humber River Health

    RECRUITING

    Toronto, Ontario, Canada

  • John Peter Smith Hospital

    RECRUITING

    Fort Worth, Texas, 76104, United States

  • Louisiana State University Health Sciences Center

    RECRUITING

    New Orleans, Louisiana, 70112, United States

  • North York General Hospital

    RECRUITING

    Toronto, Ontario, Canada

  • Orlando Health Jewett Orthopedic Institute

    RECRUITING

    Orlando, Florida, 32806, United States

  • Roth | McFarlane Hand & Upper Limb Centre

    ACTIVE_NOT_RECRUITING

    London, Ontario, Canada

  • Saint John Regional Hospital

    RECRUITING

    Saint John, New Brunswick, Canada

  • Southlake Health

    RECRUITING

    Newmarket, Ontario, Canada

  • St. Joseph's Healthcare Hamilton

    RECRUITING

    Hamilton, Ontario, Canada

  • The Curtis National Hand Center

    COMPLETED

    Baltimore, Maryland, 21218, United States

  • Trillium Health Partners

    RECRUITING

    Toronto, Ontario, Canada

  • University of Alberta Hospital

    COMPLETED

    Edmonton, Alberta, Canada

  • University of Florida Health

    RECRUITING

    Gainesville, Florida, 32608, United States

  • WellSpan Health

    COMPLETED

    York, Pennsylvania, 17403, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.